Healthy potentially undervalued

Results

58

1 new

Companies which are potentially undervalued and in an acceptable financial position.

58 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
	FGR	€129.35	5.0%	10.1%	€12.3b	€161.21	12.0	7.3%	3.7%	Capital Goods
	KOF	€24.70	2.3%	-25.2%	€484.6m	€37.87	8.9	2.5%	8.9%	Consumer Durables
	INF	€37.45	-2.7%	-4.2%	€261.2m	€51.00	12.5	6.2%	5.3%	Software
	WAVE	€41.75	-4.8%	-26.5%	€1.0b	€65.23	12.5	8.6%	1.2%	Software
	EQS	€37.10	-4.6%	-21.6%	€557.7m	€55.68	15.4	12.6%	3.4%	Healthcare
	SAN	€75.66	-1.8%	-10.8%	€90.8b	€96.70	18.8	17.0%	5.4%	Pharmaceuticals & Biotech
	VETO	€68.90	-1.7%	-0.4%	€800.8m	€90.38	14.0	3.9%	1.3%	Pharmaceuticals & Biotech
	HO	€228.10	-1.5%	-8.1%	€46.9b	€294.72	28.0	11.4%	1.7%	Capital Goods
	SK	€54.60	2.8%	-34.3%	€3.0b	€73.45	12.2	22.7%	5.1%	Consumer Durables
	VIRP	€337.00	-2.2%	6.3%	€2.8b	€412.88	18.7	10.2%	0.4%	Pharmaceuticals & Biotech
	FRVIA	€10.01	2.6%	20.9%	€2.0b	€14.96	0.1	111.6%	n/a	Automobiles
	GLO	€33.25	1.5%	28.6%	€975.3m	€36.75	11.9	13.1%	2.7%	Commercial Services
	BON	€8.02	2.3%	-9.3%	€257.6m	€8.08	11.2	20.4%	3.1%	Food, Beverage & Tobacco
	URW	€99.50	2.1%	19.9%	€14.3b	€116.09	0.8	11.8%	4.5%	Real Estate
	MDM	€0.44	3.2%	-82.5%	€16.8m	€2.27	0.0	95.2%	0%	Retail
	ALCLS	€2.69	7.1%	112.1%	€195.3m	€6.50	3.0	-16.1%	n/a	Pharmaceuticals & Biotech
	UBI	€4.88	-1.7%	-47.2%	€656.4m	€5.60	0.5	120.5%	n/a	Media
	AKE	€58.15	1.1%	-3.6%	€4.4b	€63.63	258.8	41.6%	6.2%	Materials
	TFI	€6.80	-2.1%	-19.3%	€1.4b	€8.02	10.0	-2.4%	9.3%	Media
	BIM	€68.10	-4.5%	-43.0%	€8.0b	€90.20	20.2	11.2%	1.4%	Healthcare
	FNAC	€34.45	-0.3%	6.8%	€1.0b	€37.00	0.1	76.7%	2.9%	Retail
	DBG	€10.09	1.9%	81.1%	€1.6b	€10.26	12.1	17.0%	1.3%	Commercial Services
	TTE	€73.05	-4.5%	31.6%	€162.5b	€85.35	12.5	3.6%	4.9%	Energy
	AM	€299.20	1.3%	-1.9%	€23.2b	€357.71	23.7	14.6%	1.6%	Capital Goods

Page 1 of 2